Financial Contrast: Akamai Technologies (NASDAQ:AKAM) and ChronoScale Corporation Common Stock (NASDAQ:CHRN)

Akamai Technologies (NASDAQ:AKAM) and ChronoScale Corporation Common Stock (NASDAQ:CHRN) are both technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.

Earnings and Valuation

This table compares Akamai Technologies and ChronoScale Corporation Common Stock”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akamai Technologies	$4.32 billion	3.08	$452.03 million	$2.78	33.35
ChronoScale Corporation Common Stock	$12.80 million	163.62	-$50.32 million	($4.32)	-3.33

Akamai Technologies has higher revenue and earnings than ChronoScale Corporation Common Stock. ChronoScale Corporation Common Stock is trading at a lower price-to-earnings ratio than Akamai Technologies, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Akamai Technologies and ChronoScale Corporation Common Stock, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Akamai Technologies	2	9	12	1	2.50
ChronoScale Corporation Common Stock	1	1	2	0	2.25

Akamai Technologies presently has a consensus target price of $146.00, indicating a potential upside of 57.46%. ChronoScale Corporation Common Stock has a consensus target price of $21.00, indicating a potential upside of 46.04%. Given Akamai Technologies’ stronger consensus rating and higher probable upside, analysts plainly believe Akamai Technologies is more favorable than ChronoScale Corporation Common Stock.

Profitability

This table compares Akamai Technologies and ChronoScale Corporation Common Stock’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Akamai Technologies	9.51%	11.32%	4.47%
ChronoScale Corporation Common Stock	-135.66%	-66.16%	-18.14%

Volatility and Risk

Akamai Technologies has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, ChronoScale Corporation Common Stock has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500.

Insider and Institutional Ownership

94.3% of Akamai Technologies shares are held by institutional investors. Comparatively, 6.4% of ChronoScale Corporation Common Stock shares are held by institutional investors. 2.3% of Akamai Technologies shares are held by company insiders. Comparatively, 0.3% of ChronoScale Corporation Common Stock shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Akamai Technologies beats ChronoScale Corporation Common Stock on 13 of the 15 factors compared between the two stocks.

About Akamai Technologies

Akamai Technologies, Inc. provides cloud computing, security, and content delivery services in the United States and internationally. The company offers cloud solutions to keep infrastructure, websites, applications, application programming interfaces, and users safe from various cyberattacks and online threats while enhancing performance. It also provides web and mobile performance solutions to enable dynamic websites and applications; media delivery solutions, including video streaming and video player services, game and software delivery, broadcast operations, authoritative domain name system, resolution, and data and analytics; and cloud computing services, such as compute, storage, networking, database, and container management services to build, deploy, and secure applications and workloads. In addition, the company offers content delivery solutions; and an array of service and support to assist customers with integrating, configuring, optimizing, and managing its offerings. It sells its solutions through various channel partners. Akamai Technologies, Inc. was incorporated in 1998 and is headquartered in Cambridge, Massachusetts.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.